SSI Executive Conversations

by Darwin Shurig

The SSI Team meets with the executives from across the Medtech, pharma, and life science space and brings fascinating insights to our following.

Podcast episodes

  • Season 1

  • Executive Conversation with Robert Wolfarth - Regualtory Affairs strategies part 2

    Executive Conversation with Robert Wolfarth - Regualtory Affairs strategies part 2

    On this next SSI Executive Conversation episode, Darwin and Robert explore the nuances of regulatory pathways in the medical industry. They dissect critical insights, including the need to avoid a transactional approach in regulatory processes and the importance of strategic planning to mitigate risks. The podcast sheds light on the high rate of FDA rejections for 510K applications and emphasizes the significance of emotional intelligence in regulatory professionals for successful submissions. Furthermore, considerations between consulting and full-time positions within the RA career path. You can contact Robert at www.CadenceRegulatory.com #RegulatoryInsights #MedicalIndustry #StrategicPlanning

  • Executive Conversation with Kevin Posey- The Strategic Importance of Regulatory and Quality in the Medical Device Industry

    Executive Conversation with Kevin Posey- The Strategic Importance of Regulatory and Quality in the Medical Device Industry

    Kevin Posey is a Subject Matter Expert in MedTech RA/QA with over 25 years of experience, working at companies ranging in size. In this episode, Darwin and Kevin talk about resource/responsibility management at small vs. big companies, The strategic importance of RA/QA, and the value of developing high emotional intelligence to communicate with governing bodies such as the FDA. To visit Kevin's LinkedIn page, click here.

  • SSI Executive Conversations- Creating Sustainable Profitable Growth: KPI's for Success and Failure

    SSI Executive Conversations- Creating Sustainable Profitable Growth: KPI's for Success and Failure

    This bonus episode is all about Creating SPG (Sustainable Profitable Growth) and highlighting Key Performance Indicators for Success and Failure. A forefront goal of SSI is to bring value to the market via Industry Insights. We work hard to conduct top-notch research on the current landscape and present it to our audience.

  • Executive Conversation with Dr. Margaret Kalmeta- CEO of Rapid Nexus talks Nanotechnology and Executive Leadership

    Executive Conversation with Dr. Margaret Kalmeta- CEO of Rapid Nexus talks Nanotechnology and Executive Leadership

    Dr. Margaret is the CEO/Founder at Rapid Nexus Nano-Tech Wound Technology, a cutting edge wound care MedTech organization. She has decades of experience in medical research, and has a passion for solving limb loss due to chronic and complex wounds. To learn more about Rapid Nexus and their Nanotechnology, click here.

  • Executive Conversation with Berk Tas Pt.3 - CEO of SentiAR Talks Innovation and Strategy

    Executive Conversation with Berk Tas Pt.3 - CEO of SentiAR Talks Innovation and Strategy

    Berk is the CEO of SentiAR, an electrophysiology technology company that is changing the game with its product. Berk's knowledge and insights come from his long-term experience as a leader in the MedTech and Life sciences spaces. In this episode, Berk and Darwin discuss executive strategies in delegation, workload, and company growth/development. To read more about SentiAR's product click here. To visit Berk's LinkedIn click here.